Package 71610-170-45

{"route": ["ORAL"], "spl_id": "2cff8a5e-1a3e-4a4f-b916-520ce1c15a4d", "openfda": {"unii": ["48A5M73Z4Q"], "rxcui": ["259255", "617311", "617312"], "spl_set_id": ["82203824-c0aa-41dd-8dd1-13cd5063917f"], "manufacturer_name": ["Aphena Pharma Solutions - Tennessee, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "45 TABLET, FILM COATED in 1 BOTTLE (71610-170-45)", "package_ndc": "71610-170-45", "marketing_start_date": "20181005"}, {"sample": false, "description": "90 TABLET, FILM COATED in 1 BOTTLE (71610-170-60)", "package_ndc": "71610-170-60", "marketing_start_date": "20181005"}], "brand_name": "ATORVASTATIN CALCIUM", "product_id": "71610-170_2cff8a5e-1a3e-4a4f-b916-520ce1c15a4d", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["HMG-CoA Reductase Inhibitor [EPC]", "Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]"], "product_ndc": "71610-170", "generic_name": "ATORVASTATIN CALCIUM", "labeler_name": "Aphena Pharma Solutions - Tennessee, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ATORVASTATIN CALCIUM", "active_ingredients": [{"name": "ATORVASTATIN CALCIUM TRIHYDRATE", "strength": "80 mg/1"}], "application_number": "ANDA205519", "marketing_category": "ANDA", "marketing_start_date": "20160519", "listing_expiration_date": "20261231"}